Sight Sciences, Inc.
SGHT
$5.61
$0.111.91%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.70M | 20.39M | 19.91M | 19.56M | 17.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.70M | 20.39M | 19.91M | 19.56M | 17.51M |
| Cost of Revenue | 2.72M | 2.60M | 2.71M | 2.98M | 2.41M |
| Gross Profit | 16.98M | 17.79M | 17.20M | 16.59M | 15.09M |
| SG&A Expenses | 21.45M | 19.02M | 19.95M | 23.87M | 24.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.71M | 24.05M | 25.01M | 31.23M | 31.37M |
| Operating Income | -7.01M | -3.67M | -5.11M | -11.67M | -13.86M |
| Income Before Tax | -12.97M | -4.15M | -8.25M | -11.90M | -14.11M |
| Income Tax Expenses | 11.00K | 8.00K | -79.00K | 40.00K | 41.00K |
| Earnings from Continuing Operations | -12.98M | -4.16M | -8.17M | -11.94M | -14.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.98M | -4.16M | -8.17M | -11.94M | -14.15M |
| EBIT | -7.01M | -3.67M | -5.11M | -11.67M | -13.86M |
| EBITDA | -6.91M | -3.56M | -5.00M | -11.54M | -13.71M |
| EPS Basic | -0.24 | -0.08 | -0.16 | -0.23 | -0.28 |
| Normalized Basic EPS | -0.09 | -0.05 | -0.07 | -0.14 | -0.17 |
| EPS Diluted | -0.24 | -0.08 | -0.16 | -0.23 | -0.28 |
| Normalized Diluted EPS | -0.09 | -0.05 | -0.07 | -0.14 | -0.17 |
| Average Basic Shares Outstanding | 53.94M | 53.08M | 52.38M | 51.82M | 51.29M |
| Average Diluted Shares Outstanding | 53.94M | 53.08M | 52.38M | 51.82M | 51.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |